Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Merck & Co. (MRK.N)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (US$) Price Target (US$) Rating
2021-01-2581.1598.00Buy
2021-12-1272.6276.00Neutral
2022-07-1594.9698.00Neutral
2022-07-2989.3497.00Neutral
2022-10-2597.71105.00Neutral
2023-01-31107.41108.00Neutral
2023-04-24115.94117.00Neutral
2023-10-20102.67122.00Buy
2024-01-17118.13135.00Buy
2024-02-01126.38148.00Buy

Disclosures

  • Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
  • UBS expects to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.
  • Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.